echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > AJKD: Association of uremic solutes with cardiovascular death in patients with diabetic nephropathy

    AJKD: Association of uremic solutes with cardiovascular death in patients with diabetic nephropathy

    • Last Update: 2022-05-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    background:

    Background: Background:

    Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD), especially those in which diabetes is the underlying cause of CKD


    Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD), especially those in which diabetes is the underlying cause of CKD


    Many low-molecular-weight organic metabolites accumulate in CKD


    SDMA and ADMA arise from the metabolism of proteins containing methylated arginine residues


    SDMA and ADMA arise from the metabolism of proteins containing methylated arginine residues


    Purpose: Purpose:

    Although there is some precedent for ADMA, SDMA, and TMAO as biomarkers for CVD in DKD, validation for clinical application is insufficient


    Although there is some precedent for ADMA, SDMA, and TMAO as biomarkers for CVD in DKD, validation for clinical application is insufficient


    method: method:

    Randomized 555 diabetic patients with EGFR<60ml/min/1.


    Randomized 555 diabetic patients with EGFR<60ml/min/1.


    Result: Result:

    The mean baseline EGFR was 44ml/min/1.


    The mean baseline EGFR was 44ml/min/1.


    Limitations: Single cohort, limited to diabetic patients with EGFR <60, potential residual confounding of GFR, no dietary information


    Table 1.


    Table 2.


    Table 2.


    Table 3.


    Table 3.
    Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with Cardiovascular Mortality

    Table 4.
    Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with All-Cause Mortality

    Table 4.
    Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with All-Cause Mortality

    Table 6
    .
    Association of baseline plasma ADMA, SDMA and TMAO with KFRT

    Table 6
    .
    Association of baseline plasma ADMA, SDMA and TMAO with KFRT

    in conclusion:

    in conclusion:

    Higher plasma concentrations and lower uremic solute U/P ratios were independently associated with CV and all-cause mortality in DKD
    .
    The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
    .

    Higher plasma concentrations and lower uremic solute U/P ratios were independently associated with CV and all-cause mortality in DKD
    .
    The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
    .
    Higher plasma concentrations and lower uremic solute U/P ratios were independently associated with CV and all-cause mortality in DKD
    .
    The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
    .

    Original source: Sapa H, Gutiérrez OM, Shlipak MG, et al.
    Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Am J Kidney Dis 2022 Mar 26

    Original source: Sapa H, Gutiérrez OM, Shlipak MG, et al.
    Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Am J Kidney Dis 2022 Mar 26 Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.